chr2:208236229:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr2:209,100,953-209,119,795 |
hg38 | chr2:208,236,229-208,255,071 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.003 | chondrosarcoma | The study shows that if an IDH1 mutation were detected in a primary central chon... | BeFree | 25432631 | Detail |
0.003 | chondrosarcoma | Here, we identified the spectrum of IDH mutations in human enchondromas and chon... | BeFree | 25730874 | Detail |
0.002 | Chromosome Aberrations | NA | GAD | Detail | |
<0.001 | Congenital chromosomal disease | Recent investigations of malignant gliomas have identified additional genetic an... | BeFree | 25471051 | Detail |
<0.001 | ulcerative colitis | NA | BeFree | Detail | |
<0.001 | colorectal carcinoma | We therefore examined IDH1 alteration as a potential cause of CIMP in colorectal... | BeFree | 25496513 | Detail |
<0.001 | colorectal carcinoma | Mathematical analysis predicts imbalanced IDH1/2 expression associates with 2-HG... | BeFree | 25586680 | Detail |
<0.001 | common cold | NA | BeFree | Detail | |
<0.001 | craniopharyngioma | NA | BeFree | Detail | |
0.241 | Enchondromatosis | Mutant IDH is sufficient to initiate enchondromatosis in mice. | BeFree,CTD_human,ORPHANET | 25730874 | Detail |
<0.001 | Ependymoma | NA | BeFree | Detail | |
<0.001 | epilepsy | NA | BeFree | Detail | |
<0.001 | fibrosarcoma | NA | BeFree | Detail | |
<0.001 | Giant Cell Tumors | Mutations of isocitrate dehydrogenase 1/2 (IDH1/2) have been reported in gliomas... | BeFree | 25324168 | Detail |
0.121 | hemangioma | NA | BeFree,CTD_human | Detail | |
0.005 | Hematological Disease | NA | BeFree,GAD | Detail | |
<0.001 | hepatitis | The frequencies of KRAS and IDHs mutations, which are associated with poor disea... | BeFree | 25636086 | Detail |
<0.001 | hepatitis A | The frequencies of KRAS and IDHs mutations, which are associated with poor disea... | BeFree | 25636086 | Detail |
0.003 | HIV Infections | NA | BeFree,GAD | Detail | |
<0.001 | Angioimmunoblastic Lymphadenopathy | NA | BeFree | Detail | |
<0.001 | Kidney Failure, Acute | NA | BeFree | Detail | |
<0.001 | Vulvar Lichen Sclerosus | NA | BeFree | Detail | |
0.004 | leukemia | Polymerase chain reaction (PCR) and direct sequencing were performed on exon 4 o... | BeFree | 24936872 | Detail |
0.004 | leukemia | Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyg... | BeFree | 25398939 | Detail |
0.004 | leukemia | Our study provides proof of concept for the molecular and biological activity of... | BeFree | 26436839 | Detail |
0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.001 | myeloid leukemia | NA | BeFree | Detail | |
<0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
0.002 | Leukemia, Myelomonocytic, Chronic | NA | GAD | Detail | |
<0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
0.002 | Lung Neoplasms | NA | GAD | Detail | |
<0.001 | lymphoma | NA | BeFree | Detail | |
0.003 | Lymphoma, Non-Hodgkin | NA | BeFree,GAD | Detail | |
0.121 | Maffucci syndrome | NA | BeFree,ORPHANET | Detail | |
<0.001 | paroxysmal nocturnal hemoglobinuria | No IDH1 R132 and IDH2 R172 mutations were identified in the entire cohort, where... | BeFree | 25486927 | Detail |
0.004 | melanoma | Therefore, we propose that IDH1 may serve as a valuable target for melanoma ther... | BeFree,GAD | 26049021 | Detail |
<0.001 | Metabolic Diseases | NA | BeFree | Detail | |
0.002 | Monosomy | NA | GAD | Detail | |
<0.001 | Acute Myeloid Leukemia, M1 | NA | BeFree | Detail | |
0.005 | Myeloproliferative disease | We performed polymerase chain reaction-denaturing high performance liquid chroma... | BeFree,GAD | 25486927 | Detail |
0.003 | Neoplasm Metastasis | NA | BeFree,GAD | Detail | |
0.002 | Nervous System Neoplasms | NA | GAD | Detail | |
<0.001 | osteosarcoma | NA | BeFree | Detail | |
0.002 | Pancreatic Neoplasm | NA | GAD | Detail | |
<0.001 | paraganglioma | NA | BeFree | Detail | |
<0.001 | pheochromocytoma | IDH1 and IDH2 mutations are found in many neoplasms, and germline alterations in... | BeFree | 25766404 | Detail |
0.003 | polycythemia vera | NA | BeFree,GAD | Detail | |
<0.001 | Precancerous Conditions | NA | BeFree | Detail | |
0.010 | Preleukemia | We performed polymerase chain reaction-denaturing high performance liquid chroma... | BeFree,GAD | 25486927 | Detail |
0.002 | Seizures | IDH1/2 mutation is associated with seizure as an initial symptom in low-grade gl... | BeFree | 25524848 | Detail |
0.002 | Skin Neoplasms | NA | GAD | Detail | |
<0.001 | Soft Tissue Neoplasms | NA | BeFree | Detail | |
0.003 | Supratentorial Neoplasms | NA | BeFree,GAD | Detail | |
0.003 | Thrombocythemia, Essential | NA | BeFree,GAD | Detail | |
0.003 | Thyroid Neoplasm | NA | BeFree,GAD | Detail | |
<0.001 | Central Nervous System Neoplasms | NA | BeFree | Detail | |
<0.001 | Li-Fraumeni syndrome | NA | BeFree | Detail | |
<0.001 | acute leukemia | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of brain | NA | BeFree | Detail | |
<0.001 | Tumor Progression | It is plausible that the NRF2 pathway plays an important role in tumor progressi... | BeFree | 25304134 | Detail |
0.003 | Neuroectodermal Tumor, Primitive | NA | BeFree,GAD | Detail | |
<0.001 | Follicular thyroid carcinoma | NA | BeFree | Detail | |
0.002 | Medullary carcinoma | NA | GAD | Detail | |
0.122 | cholangiocarcinoma | Exome and the following prevalence sequencing identified mutations of the BAP1, ... | BeFree,CTD_human | 24532422 | Detail |
0.122 | cholangiocarcinoma | Recent whole-exome and targeted sequencing not only confirmed frequent mutations... | BeFree,CTD_human | 25693006 | Detail |
<0.001 | Neoplasms, Neuroepithelial | NA | BeFree | Detail | |
<0.001 | ganglioglioma | NA | BeFree | Detail | |
0.121 | gliosarcoma | NA | BeFree,ORPHANET | Detail | |
0.001 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
<0.001 | pediatric acute myeloblastic leukemia | NA | BeFree | Detail | |
<0.001 | Lesion of brain | NA | BeFree | Detail | |
<0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Neoplasm, Residual | NA | BeFree | Detail | |
<0.001 | Telangiectatic osteosarcoma | Using Sanger sequencing, we determined the frequency of H3F3A, H3F3B, IDH1, and ... | BeFree | 26457357 | Detail |
<0.001 | mixed gliomas | NA | BeFree | Detail | |
<0.001 | Acute respiratory failure | NA | BeFree | Detail | |
<0.001 | Petit mal status | NA | BeFree | Detail | |
<0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
<0.001 | chondroblastic osteosarcoma | NA | BeFree | Detail | |
0.001 | Solid tumour | The role of mutant IDH in controlling hepatic differentiation state suggests the... | BeFree | 25485496 | Detail |
<0.001 | secondary acute myeloid leukemia | The fourth clonal group (including IDH1 and RUNX1) was acquired at sAML transfor... | BeFree | 25252869 | Detail |
<0.001 | high-grade childhood cerebral astrocytoma | Absence of IDH1/G-CIMP status further indicates that findings in adult GBM canno... | BeFree | 24997139 | Detail |
0.002 | diffuse astrocytoma | The mean of Olig2 LI of gliomas with 1p/19q loss ± IDH1/2 mutation, the majority... | BeFree | 25085214 | Detail |
0.001 | mixed oligodendroglioma-astrocytoma | After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly as... | BeFree | 25853694 | Detail |
<0.001 | Vascular Neoplasms | NA | BeFree | Detail | |
0.001 | gliomatosis cerebri | NA | BeFree | Detail | |
0.007 | anaplastic astrocytoma | The IDH1 mutation status was also determined in patients with anaplastic astrocy... | BeFree | 24929863 | Detail |
0.007 | anaplastic astrocytoma | A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative... | BeFree | 25471051 | Detail |
0.007 | anaplastic astrocytoma | IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation ... | BeFree | 25962792 | Detail |
0.002 | pilocytic astrocytoma | NA | BeFree | Detail | |
0.120 | giant cell glioblastoma | NA | ORPHANET | Detail | |
<0.001 | Malignant neoplasm of liver | NA | BeFree | Detail | |
0.002 | intrahepatic cholangiocarcinoma | Cholangiolar-type intrahepatic cholangiocarcinomas had a higher frequency of IDH... | BeFree | 24406866 | Detail |
0.002 | intrahepatic cholangiocarcinoma | In line with these findings, human ICC with IDH mutations are characterized by a... | BeFree | 25485496 | Detail |
<0.001 | pilocytic astrocytoma of cerebellum | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of prostate | Massively parallel paired-end sequencing of whole genomes of 10 primary chondros... | BeFree | 25024164 | Detail |
0.002 | Hematologic Neoplasms | IDH1- and IDH2-mutant primary human AML cells were more sensitive than IDH1/2 wi... | BeFree | 25599133 | Detail |
<0.001 | Nijmegen breakage syndrome | NA | BeFree | Detail | |
<0.001 | Chromosome 8, trisomy | NA | BeFree | Detail | |
<0.001 | Chondrogenic Neoplasm | A recent comprehensive analysis of mesenchymal tumors identified an IDH1/2 mutat... | BeFree | 25250651 | Detail |
<0.001 | Chondrogenic Neoplasm | However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recent... | BeFree | 25993236 | Detail |
<0.001 | Recurrent tumor | NA | BeFree | Detail | |
0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
0.001 | Leukemogenesis | Overall, our data suggest that IDH mutations are rare in the preleukemic disorde... | BeFree | 25486927 | Detail |
<0.001 | Tumor Initiation | NA | BeFree | Detail | |
<0.001 | prostate carcinoma | Massively parallel paired-end sequencing of whole genomes of 10 primary chondros... | BeFree | 25024164 | Detail |
<0.001 | Glioma of brainstem | Survival outcomes for adult WHO Grade II to IV brainstem gliomas were similar to... | BeFree | 25934342 | Detail |
0.004 | Primary myelofibrosis | We have studied the mutational status of TET2 (complete coding region), ASXL1 (e... | BeFree | 21904853 | Detail |
<0.001 | Progressive Neoplastic Disease | NA | BeFree | Detail | |
0.121 | Precursor Cell Lymphoblastic Leukemia Lymphoma | Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplas... | BeFree | 20538800 | Detail |
0.001 | Acute lymphocytic leukemia | Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplas... | BeFree | 20538800 | Detail |
0.003 | Thrombocythemia, Essential | We have studied the mutational status of TET2 (complete coding region), ASXL1 (e... | BeFree | 21904853 | Detail |
<0.001 | breast carcinoma | NA | BeFree | Detail | |
<0.001 | Myeloid Leukemia, Chronic | Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplas... | BeFree | 20538800 | Detail |
0.003 | polycythemia vera | We have studied the mutational status of TET2 (complete coding region), ASXL1 (e... | BeFree | 21904853 | Detail |
<0.001 | colon carcinoma | NA | BeFree | Detail | |
<0.001 | germ cell cancer | NA | BeFree | Detail | |
<0.001 | biliary tract cancer | IDH mutations in liver cell plasticity and biliary cancer. | BeFree | 25485496 | Detail |
0.001 | Brain Tumor, Primary | Mutations in the isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) genes suggest ... | BeFree | 25727224 | Detail |
<0.001 | Chromosome 1, monosomy 1p | There was no deletion 1p19q in 118 cases, codeletion 1p19q (57 cases), single de... | BeFree | 25261925 | Detail |
<0.001 | Chromosome 8, monosomy 8p | NA | BeFree | Detail | |
<0.001 | Chromosome 8, trisomy 8p | NA | BeFree | Detail | |
<0.001 | breast adenocarcinoma | NA | BeFree | Detail | |
<0.001 | dedifferentiated chondrosarcoma | However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recent... | BeFree | 25993236 | Detail |
<0.001 | dedifferentiated chondrosarcoma | Deep parallel sequencing of the dedifferentiated component showed a nonsynonymou... | BeFree | 26198745 | Detail |
0.121 | chondroma | We here described clinical and pathological features in a new case of convexity ... | BeFree,CTD_human | 25250651 | Detail |
<0.001 | Intestinal adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Chronic myeloproliferative disorder | We performed polymerase chain reaction-denaturing high performance liquid chroma... | BeFree | 25486927 | Detail |
<0.001 | Single tumor | NA | BeFree | Detail | |
<0.001 | spindle cell hemangioma | NA | BeFree | Detail | |
<0.001 | Astrocytoma, low grade | NA | BeFree | Detail | |
<0.001 | Oligodendroglial Neoplasm | Adult LGG are characterized by IDH1/2 mutations and ATRX mutations in astrocytic... | BeFree | 25664944 | Detail |
<0.001 | Oligodendroglial Neoplasm | We conclude that the majority of IDLGGs are IDH1 mutated and are predominantly o... | BeFree | 25674227 | Detail |
<0.001 | Conventional Chondrosarcoma | Massively parallel paired-end sequencing of whole genomes of 10 primary chondros... | BeFree | 25024164 | Detail |
<0.001 | Conventional Chondrosarcoma | Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in... | BeFree | 25432631 | Detail |
<0.001 | Conventional Chondrosarcoma | However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recent... | BeFree | 25993236 | Detail |
<0.001 | Vascular lesions | NA | BeFree | Detail | |
0.002 | oxyphilic adenoma | NA | GAD | Detail | |
0.002 | Primary Glioblastoma | The large majority of lower-grade gliomas without an IDH mutation had genomic ab... | BeFree | 26061751 | Detail |
0.005 | Secondary Glioblastoma | Comparison of our sGBM data with TCGA pGBM data indicate that IDH1 mutated GBM s... | BeFree | 25012071 | Detail |
0.005 | Secondary Glioblastoma | IDH1/2 mutations are tightly associated with grade II and III gliomas and second... | BeFree | 25078896 | Detail |
0.005 | Secondary Glioblastoma | Somatic mutation of isocitrate dehydrogenase 1 (IDH1) is now recognized as the m... | BeFree | 25225364 | Detail |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
<0.001 | colorectal cancer | We therefore examined IDH1 alteration as a potential cause of CIMP in colorectal... | BeFree | 25496513 | Detail |
<0.001 | colorectal cancer | Mathematical analysis predicts imbalanced IDH1/2 expression associates with 2-HG... | BeFree | 25586680 | Detail |
<0.001 | Neoplasms, Intracranial | NA | BeFree | Detail | |
<0.001 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | NA | BeFree | Detail | |
<0.001 | Neurocytoma | NA | BeFree | Detail | |
<0.001 | Grade I Astrocytoma | NA | BeFree | Detail | |
<0.001 | Enchondroma | Taken together, these data show that mutant IDH or d-2HG causes persistence of c... | BeFree | 25730874 | Detail |
<0.001 | Enchondroma | However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recent... | BeFree | 25993236 | Detail |
<0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
<0.001 | D-2-hydroxyglutaric aciduria | NA | BeFree | Detail | |
<0.001 | MULTICYSTIC RENAL DYSPLASIA, BILATERAL | NA | BeFree | Detail | |
0.121 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,CTD_human | Detail | |
0.121 | liver carcinoma | Our results for the first time suggest that IDH gene polymorphisms may serve as ... | BeFree,CTD_human | 25355558 | Detail |
<0.001 | combined D-2- and L-2-hydroxyglutaric aciduria | NA | BeFree | Detail | |
0.010 | myelodysplastic syndrome | We performed polymerase chain reaction-denaturing high performance liquid chroma... | BeFree,GAD | 25486927 | Detail |
<0.001 | Progressive cGVHD | NA | BeFree | Detail | |
0.120 | METAPHYSEAL ENCHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA | NA | ORPHANET | Detail | |
<0.001 | Radiation Damage | NA | BeFree | Detail | |
0.001 | Cytogenetically normal acute myeloid leukemia | NA | BeFree | Detail | |
<0.001 | Congenital Abnormality | NA | BeFree | Detail | |
<0.001 | adenocarcinoma | NA | BeFree | Detail | |
0.004 | Primary myelofibrosis | The fourth clonal group (including IDH1 and RUNX1) was acquired at sAML transfor... | BeFree,GAD | 25252869 | Detail |
<0.001 | aplastic anemia | We performed polymerase chain reaction-denaturing high performance liquid chroma... | BeFree | 25486927 | Detail |
<0.001 | Mental disorders | NA | BeFree | Detail | |
0.006 | Blast Phase | NA | BeFree,GAD | Detail | |
<0.001 | Bone neoplasms | These tumors are characterized by frequent gain-of-function mutations in the iso... | BeFree | 25485496 | Detail |
0.040 | Brain Neoplasms | We used human glioma tissues and derived brain tumor stem cells (BTSCs) to study... | BeFree,GAD | 24366912 | Detail |
0.040 | Brain Neoplasms | Somatic mutation of isocitrate dehydrogenase 1 (IDH1) is now recognized as the m... | BeFree,GAD | 25225364 | Detail |
<0.001 | Malignant neoplasm of breast | NA | BeFree | Detail | |
<0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
<0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail | |
0.002 | Carcinoma, Papillary | NA | GAD | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
The study shows that if an IDH1 mutation were detected in a primary central chondrosarcoma, it is al... | DisGeNET | Detail |
Here, we identified the spectrum of IDH mutations in human enchondromas and chondrosarcomas and stud... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Recent investigations of malignant gliomas have identified additional genetic and chromosomal abnorm... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We therefore examined IDH1 alteration as a potential cause of CIMP in colorectal cancer. | DisGeNET | Detail |
Mathematical analysis predicts imbalanced IDH1/2 expression associates with 2-HG-inactivating β-oxyg... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mutant IDH is sufficient to initiate enchondromatosis in mice. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mutations of isocitrate dehydrogenase 1/2 (IDH1/2) have been reported in gliomas and other types of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The frequencies of KRAS and IDHs mutations, which are associated with poor disease-free survival, we... | DisGeNET | Detail |
The frequencies of KRAS and IDHs mutations, which are associated with poor disease-free survival, we... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Polymerase chain reaction (PCR) and direct sequencing were performed on exon 4 of IDH1/2 genes and m... | DisGeNET | Detail |
Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in Drosophi... | DisGeNET | Detail |
Our study provides proof of concept for the molecular and biological activity of novel allosteric in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
No IDH1 R132 and IDH2 R172 mutations were identified in the entire cohort, whereas IDH1 G105G allele... | DisGeNET | Detail |
Therefore, we propose that IDH1 may serve as a valuable target for melanoma therapy. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We performed polymerase chain reaction-denaturing high performance liquid chromatography (PCR-DHPLC)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
IDH1 and IDH2 mutations are found in many neoplasms, and germline alterations in SDH genes and FH pr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We performed polymerase chain reaction-denaturing high performance liquid chromatography (PCR-DHPLC)... | DisGeNET | Detail |
IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: A report of 31... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
It is plausible that the NRF2 pathway plays an important role in tumor progression of anaplastic gli... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Exome and the following prevalence sequencing identified mutations of the BAP1, ARID1A, IDH1 and IDH... | DisGeNET | Detail |
Recent whole-exome and targeted sequencing not only confirmed frequent mutations in known CCA-relate... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using Sanger sequencing, we determined the frequency of H3F3A, H3F3B, IDH1, and IDH2 mutations in GC... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The role of mutant IDH in controlling hepatic differentiation state suggests the potential of newly ... | DisGeNET | Detail |
The fourth clonal group (including IDH1 and RUNX1) was acquired at sAML transformation and was predo... | DisGeNET | Detail |
Absence of IDH1/G-CIMP status further indicates that findings in adult GBM cannot be simply extrapol... | DisGeNET | Detail |
The mean of Olig2 LI of gliomas with 1p/19q loss ± IDH1/2 mutation, the majority of them being oligo... | DisGeNET | Detail |
After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly associated with poorer... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The IDH1 mutation status was also determined in patients with anaplastic astrocytomas and AOA, and A... | DisGeNET | Detail |
A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telo... | DisGeNET | Detail |
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little differenc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cholangiolar-type intrahepatic cholangiocarcinomas had a higher frequency of IDH1 or 2 mutations tha... | DisGeNET | Detail |
In line with these findings, human ICC with IDH mutations are characterized by a hepatic progenitor ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Massively parallel paired-end sequencing of whole genomes of 10 primary chondrosarcomas revealed tha... | DisGeNET | Detail |
IDH1- and IDH2-mutant primary human AML cells were more sensitive than IDH1/2 wild-type cells to ABT... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A recent comprehensive analysis of mesenchymal tumors identified an IDH1/2 mutation in cartilaginous... | DisGeNET | Detail |
However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recently have been identif... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overall, our data suggest that IDH mutations are rare in the preleukemic disorders and may not be th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Massively parallel paired-end sequencing of whole genomes of 10 primary chondrosarcomas revealed tha... | DisGeNET | Detail |
Survival outcomes for adult WHO Grade II to IV brainstem gliomas were similar to supratentorial IDH1... | DisGeNET | Detail |
We have studied the mutational status of TET2 (complete coding region), ASXL1 (exon12), IDH1 (R132),... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplasias (n = 96), a sing... | DisGeNET | Detail |
Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplasias (n = 96), a sing... | DisGeNET | Detail |
We have studied the mutational status of TET2 (complete coding region), ASXL1 (exon12), IDH1 (R132),... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Moreover, we identified IDH mutations in 2 JAK2 V617F myeloproliferative neoplasias (n = 96), a sing... | DisGeNET | Detail |
We have studied the mutational status of TET2 (complete coding region), ASXL1 (exon12), IDH1 (R132),... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
IDH mutations in liver cell plasticity and biliary cancer. | DisGeNET | Detail |
Mutations in the isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) genes suggest a role for this abno... | DisGeNET | Detail |
There was no deletion 1p19q in 118 cases, codeletion 1p19q (57 cases), single deletion 1p (4 cases) ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recently have been identif... | DisGeNET | Detail |
Deep parallel sequencing of the dedifferentiated component showed a nonsynonymous mutation at exon 4... | DisGeNET | Detail |
We here described clinical and pathological features in a new case of convexity dural chondroma with... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We performed polymerase chain reaction-denaturing high performance liquid chromatography (PCR-DHPLC)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Adult LGG are characterized by IDH1/2 mutations and ATRX mutations in astrocytic tumors and IDH1/2 m... | DisGeNET | Detail |
We conclude that the majority of IDLGGs are IDH1 mutated and are predominantly oligodendroglial tumo... | DisGeNET | Detail |
Massively parallel paired-end sequencing of whole genomes of 10 primary chondrosarcomas revealed tha... | DisGeNET | Detail |
Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondr... | DisGeNET | Detail |
However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recently have been identif... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The large majority of lower-grade gliomas without an IDH mutation had genomic aberrations and clinic... | DisGeNET | Detail |
Comparison of our sGBM data with TCGA pGBM data indicate that IDH1 mutated GBM samples have very sim... | DisGeNET | Detail |
IDH1/2 mutations are tightly associated with grade II and III gliomas and secondary glioblastomas, w... | DisGeNET | Detail |
Somatic mutation of isocitrate dehydrogenase 1 (IDH1) is now recognized as the most common initiatin... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We therefore examined IDH1 alteration as a potential cause of CIMP in colorectal cancer. | DisGeNET | Detail |
Mathematical analysis predicts imbalanced IDH1/2 expression associates with 2-HG-inactivating β-oxyg... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, these data show that mutant IDH or d-2HG causes persistence of chondrocytes, giving ... | DisGeNET | Detail |
However, heterozygous mutations in isocitrate dehydrogenase (IDH) enzymes recently have been identif... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results for the first time suggest that IDH gene polymorphisms may serve as an independent progn... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We performed polymerase chain reaction-denaturing high performance liquid chromatography (PCR-DHPLC)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The fourth clonal group (including IDH1 and RUNX1) was acquired at sAML transformation and was predo... | DisGeNET | Detail |
We performed polymerase chain reaction-denaturing high performance liquid chromatography (PCR-DHPLC)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These tumors are characterized by frequent gain-of-function mutations in the isocitrate dehydrogenas... | DisGeNET | Detail |
We used human glioma tissues and derived brain tumor stem cells (BTSCs) to study the expression of H... | DisGeNET | Detail |
Somatic mutation of isocitrate dehydrogenase 1 (IDH1) is now recognized as the most common initiatin... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg38
- Position
- chr2:208,236,229-208,255,071
- Variant Type
- snv
Genome browser